_id
691484f4ccc777a4e85d9554
Ticker
NUVL
Name
Nuvalent Inc
Exchange
NASDAQ
Address
One Broadway, Cambridge, MA, United States, 02142
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.nuvalent.com
Description
Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are NVL-520, a novel ROS1-selective inhibitor to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of ROS1 tyrosine kinase inhibitors (TKIs) for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC) which is under the Phase 2 portion of the ARROS-1 Phase 1/2 clinical trial; NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under the Phase 2 portion of the ALKOVE-1 clinical trial; and NVL-330, a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to treat tumors driven by HER2ex20, brain metastases, and avoiding treatment-limiting adverse events including due to off-target inhibition of wild-type EGFR that is in Phase 1a/1b clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Last Close
104.97
Volume
1076632
Current Price
102.775
Change
-2.0910736400876377
Last Updated
2025-12-02T12:48:33.882Z
Image
-
Ipo Date
2021-07-29T00:00:00.000Z
Market Cap
7737447936
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.11261666666666664
Sentiment Sources
24
Rating
4.7273
Target Price
141.8235
Strong Buy
8
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
112696000
Operating Income
-112696000
Interest Expense
10201000
Pretax Income
-122305000
Net Income
-122437000
Eps
-1.6971322115297316
Dividends Per Share
-
Shares Outstanding
67271461
Income Tax Expense
132000
EBITDA
-122305000
Operating Margin
-
Total Other Income Expense Net
-9609000
Cash
115752000
Short Term Investments
827351000
Receivables
-
Inventories
-
Total Current Assets
956945000
Property Plant Equipment
-
Total Assets
979910000
Payables
22010000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
134511000
Equity
845399000
Depreciation
-
Change In Working Capital
11939000
Cash From Operations
-70462000
Capital Expenditures
0
Cash From Investing
53971000
Cash From Financing
4773000
Net Change In Cash
-11718000
PE
-
PB
8.77046781241757
ROE
-14.482747199842914
ROA
-12.494718902756375
FCF
-70462000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
112696000
Quarters > 0 > income Statement > operating Income
-112696000
Quarters > 0 > income Statement > interest Expense
10201000
Quarters > 0 > income Statement > pretax Income
-122305000
Quarters > 0 > income Statement > net Income
-122437000
Quarters > 0 > income Statement > eps
-1.6971322115297316
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
72143466
Quarters > 0 > income Statement > income Tax Expense
132000
Quarters > 0 > income Statement > EBITDA
-122305000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-9609000
Quarters > 0 > balance Sheet > cash
115752000
Quarters > 0 > balance Sheet > short Term Investments
827351000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
956945000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
979910000
Quarters > 0 > balance Sheet > payables
22010000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
134511000
Quarters > 0 > balance Sheet > equity
845399000
Quarters > 0 > cash Flow > net Income
-122437000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
11939000
Quarters > 0 > cash Flow > cash From Operations
-70462000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
53971000
Quarters > 0 > cash Flow > cash From Financing
4773000
Quarters > 0 > cash Flow > net Change In Cash
-11718000
Quarters > 0 > ratios > PE
-1.6971322115297316
Quarters > 0 > ratios > PB
8.77046781241757
Quarters > 0 > ratios > ROE
-14.482747199842914
Quarters > 0 > ratios > ROA
-12.494718902756375
Quarters > 0 > ratios > FCF
-70462000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
104571000
Quarters > 1 > income Statement > operating Income
-104571000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-99508000
Quarters > 1 > income Statement > net Income
-99653000
Quarters > 1 > income Statement > eps
-1.3870791364607322
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
71843774
Quarters > 1 > income Statement > income Tax Expense
145000
Quarters > 1 > income Statement > EBITDA
-104571000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
5063000
Quarters > 1 > balance Sheet > cash
127470000
Quarters > 1 > balance Sheet > short Term Investments
878128000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1019610000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
1040543000
Quarters > 1 > balance Sheet > payables
13342000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
100801000
Quarters > 1 > balance Sheet > equity
939742000
Quarters > 1 > cash Flow > net Income
-99653000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-2450000
Quarters > 1 > cash Flow > cash From Operations
-76598000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
77478000
Quarters > 1 > cash Flow > cash From Financing
5755000
Quarters > 1 > cash Flow > net Change In Cash
6635000
Quarters > 1 > ratios > PE
-1.3870791364607322
Quarters > 1 > ratios > PB
7.857203224768075
Quarters > 1 > ratios > ROE
-10.604293518859432
Quarters > 1 > ratios > ROA
-9.57701892185138
Quarters > 1 > ratios > FCF
-76598000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
94812000
Quarters > 2 > income Statement > operating Income
-94812000
Quarters > 2 > income Statement > interest Expense
11817000
Quarters > 2 > income Statement > pretax Income
-84425000
Quarters > 2 > income Statement > net Income
-84582000
Quarters > 2 > income Statement > eps
-1.1811808736454028
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
71608000
Quarters > 2 > income Statement > income Tax Expense
157000
Quarters > 2 > income Statement > EBITDA
-94812000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
10387000
Quarters > 2 > balance Sheet > cash
120835000
Quarters > 2 > balance Sheet > short Term Investments
952390000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1086553000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
1105806000
Quarters > 2 > balance Sheet > payables
26165000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
94749000
Quarters > 2 > balance Sheet > equity
1011057000
Quarters > 2 > cash Flow > net Income
-84582000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
12202000
Quarters > 2 > cash Flow > cash From Operations
-54821000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
25417000
Quarters > 2 > cash Flow > cash From Financing
4548000
Quarters > 2 > cash Flow > net Change In Cash
-24856000
Quarters > 2 > ratios > PE
-1.1811808736454028
Quarters > 2 > ratios > PB
7.279027987541751
Quarters > 2 > ratios > ROE
-8.36570045012299
Quarters > 2 > ratios > ROA
-7.648900440041021
Quarters > 2 > ratios > FCF
-54821000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
86299000
Quarters > 3 > income Statement > operating Income
-86299000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-74592000
Quarters > 3 > income Statement > net Income
-74763000
Quarters > 3 > income Statement > eps
-1.0506914385294284
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
71156000
Quarters > 3 > income Statement > income Tax Expense
171000
Quarters > 3 > income Statement > EBITDA
-86299000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
11707000
Quarters > 3 > balance Sheet > cash
145691000
Quarters > 3 > balance Sheet > short Term Investments
972611000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1132448000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
1141752000
Quarters > 3 > balance Sheet > payables
5225000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
71960000
Quarters > 3 > balance Sheet > equity
1069792000
Quarters > 3 > cash Flow > net Income
-74763000
Quarters > 3 > cash Flow > depreciation
-52588000
Quarters > 3 > cash Flow > change In Working Capital
218000
Quarters > 3 > cash Flow > cash From Operations
-62000000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-170045000
Quarters > 3 > cash Flow > cash From Financing
8492000
Quarters > 3 > cash Flow > net Change In Cash
-223553000
Quarters > 3 > ratios > PE
-1.0506914385294284
Quarters > 3 > ratios > PB
6.835962411384643
Quarters > 3 > ratios > ROE
-6.98855478448147
Quarters > 3 > ratios > ROA
-6.548094507388645
Quarters > 3 > ratios > FCF
-62000000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
280368000
Annuals > 0 > income Statement > operating Income
-280368000
Annuals > 0 > income Statement > interest Expense
38316000
Annuals > 0 > income Statement > pretax Income
-259992000
Annuals > 0 > income Statement > net Income
-260756000
Annuals > 0 > income Statement > eps
-3.926515984279239
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
66409000
Annuals > 0 > income Statement > income Tax Expense
764000
Annuals > 0 > income Statement > EBITDA
-280368000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
20376000
Annuals > 0 > balance Sheet > cash
145691000
Annuals > 0 > balance Sheet > short Term Investments
972611000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1132448000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
1141752000
Annuals > 0 > balance Sheet > payables
5225000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
71960000
Annuals > 0 > balance Sheet > equity
1069792000
Annuals > 0 > cash Flow > net Income
-260756000
Annuals > 0 > cash Flow > depreciation
280368000
Annuals > 0 > cash Flow > change In Working Capital
11842000
Annuals > 0 > cash Flow > cash From Operations
-185064000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-573514000
Annuals > 0 > cash Flow > cash From Financing
568882000
Annuals > 0 > cash Flow > net Change In Cash
-189696000
Annuals > 0 > ratios > PE
-3.926515984279239
Annuals > 0 > ratios > PB
6.606186791451048
Annuals > 0 > ratios > ROE
-24.374457838533097
Annuals > 0 > ratios > ROA
-22.83823457283193
Annuals > 0 > ratios > FCF
-185064000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
149492000
Annuals > 1 > income Statement > operating Income
-149492000
Annuals > 1 > income Statement > interest Expense
23273000
Annuals > 1 > income Statement > pretax Income
-126219000
Annuals > 1 > income Statement > net Income
-126219000
Annuals > 1 > income Statement > eps
-2.167854627896192
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
58223000
Annuals > 1 > income Statement > income Tax Expense
-167895
Annuals > 1 > income Statement > EBITDA
-126219000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
23273000
Annuals > 1 > balance Sheet > cash
335387000
Annuals > 1 > balance Sheet > short Term Investments
384518000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
726488000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
732384000
Annuals > 1 > balance Sheet > payables
9274000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
31823000
Annuals > 1 > balance Sheet > equity
700561000
Annuals > 1 > cash Flow > net Income
-126219000
Annuals > 1 > cash Flow > depreciation
23273000
Annuals > 1 > cash Flow > change In Working Capital
11026000
Annuals > 1 > cash Flow > cash From Operations
-99739000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-143527000
Annuals > 1 > cash Flow > cash From Financing
336847000
Annuals > 1 > cash Flow > net Change In Cash
93581000
Annuals > 1 > ratios > PE
-2.167854627896192
Annuals > 1 > ratios > PB
8.844471302284882
Annuals > 1 > ratios > ROE
-18.016846498734584
Annuals > 1 > ratios > ROA
-17.23399200419452
Annuals > 1 > ratios > FCF
-99739000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
86108000
Annuals > 2 > income Statement > operating Income
-86108000
Annuals > 2 > income Statement > interest Expense
4254000
Annuals > 2 > income Statement > pretax Income
-81854000
Annuals > 2 > income Statement > net Income
-73346000
Annuals > 2 > income Statement > eps
-1.4766957257041615
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
49669000
Annuals > 2 > income Statement > income Tax Expense
-8508000
Annuals > 2 > income Statement > EBITDA
-77600000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
4254000
Annuals > 2 > balance Sheet > cash
241806000
Annuals > 2 > balance Sheet > short Term Investments
230357000
Annuals > 2 > balance Sheet > receivables
4468000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
477991000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
482459000
Annuals > 2 > balance Sheet > payables
7195000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
19481000
Annuals > 2 > balance Sheet > equity
462978000
Annuals > 2 > cash Flow > net Income
-81854000
Annuals > 2 > cash Flow > depreciation
-373000
Annuals > 2 > cash Flow > change In Working Capital
6931000
Annuals > 2 > cash Flow > cash From Operations
-64971000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-10665000
Annuals > 2 > cash Flow > cash From Financing
248916000
Annuals > 2 > cash Flow > net Change In Cash
173280000
Annuals > 2 > ratios > PE
-1.4766957257041615
Annuals > 2 > ratios > PB
11.41690313578615
Annuals > 2 > ratios > ROE
-15.842221444647478
Annuals > 2 > ratios > ROA
-15.202535344972318
Annuals > 2 > ratios > FCF
-64971000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
45817000
Annuals > 3 > income Statement > operating Income
-45817000
Annuals > 3 > income Statement > interest Expense
521000
Annuals > 3 > income Statement > pretax Income
-46338000
Annuals > 3 > income Statement > net Income
-46338000
Annuals > 3 > income Statement > eps
-2.127157546823357
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
21784000
Annuals > 3 > income Statement > income Tax Expense
521000
Annuals > 3 > income Statement > EBITDA
-46123000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-521000
Annuals > 3 > balance Sheet > cash
68526000
Annuals > 3 > balance Sheet > short Term Investments
219585000
Annuals > 3 > balance Sheet > receivables
3196000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
290628000
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
293824000
Annuals > 3 > balance Sheet > payables
2893000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8787000
Annuals > 3 > balance Sheet > equity
285037000
Annuals > 3 > cash Flow > net Income
-46338000
Annuals > 3 > cash Flow > depreciation
215000
Annuals > 3 > cash Flow > change In Working Capital
1941000
Annuals > 3 > cash Flow > cash From Operations
-40000000
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-220028000
Annuals > 3 > cash Flow > cash From Financing
318222000
Annuals > 3 > cash Flow > net Change In Cash
58194000
Annuals > 3 > ratios > PE
-2.127157546823357
Annuals > 3 > ratios > PB
8.133166150359427
Annuals > 3 > ratios > ROE
-16.256836831709567
Annuals > 3 > ratios > ROA
-15.770665432367675
Annuals > 3 > ratios > FCF
-40000000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-1.6971322115297316
Valuation > metrics > PB
8.77046781241757
Valuation > final Score
20
Valuation > verdict
192.3% Overvalued
Profitability > metrics > ROE
-14.482747199842914
Profitability > metrics > ROA
-12.79457022085909
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.15910948558018168
Risk > metrics > Interest Coverage
-11.047544358396236
Risk > final Score
16
Risk > verdict
High
Liquidity > metrics > Current Ratio
43.477737392094504
Liquidity > metrics > Quick Ratio
43.477737392094504
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-23
Prev Risks > 1
28
Prev Risks > 2
31
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T23:06:05.586Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-04
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-1.38
Earnings History > 0 > eps Difference
1.38
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.7
Earnings History > 1 > eps Estimate
-1.36
Earnings History > 1 > eps Difference
-0.34
Earnings History > 1 > surprise Percent
-25
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.39
Earnings History > 2 > eps Estimate
-1.22
Earnings History > 2 > eps Difference
-0.17
Earnings History > 2 > surprise Percent
-13.9344
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-08
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.18
Earnings History > 3 > eps Estimate
-1.13
Earnings History > 3 > eps Difference
-0.05
Earnings History > 3 > surprise Percent
-4.4248
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-27
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.05
Earnings History > 4 > eps Estimate
-1.08
Earnings History > 4 > eps Difference
0.03
Earnings History > 4 > surprise Percent
2.7778
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.28
Earnings History > 5 > eps Estimate
-0.94
Earnings History > 5 > eps Difference
-0.34
Earnings History > 5 > surprise Percent
-36.1702
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.88
Earnings History > 6 > eps Estimate
-0.7631
Earnings History > 6 > eps Difference
-0.1169
Earnings History > 6 > surprise Percent
-15.3191
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.69
Earnings History > 7 > eps Estimate
-0.68
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-1.4706
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-27
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.62
Earnings History > 8 > eps Estimate
-0.6
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-3.3333
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-14
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.59
Earnings History > 9 > eps Estimate
-0.58
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-1.7241
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-10
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.51
Earnings History > 10 > eps Estimate
-0.53
Earnings History > 10 > eps Difference
0.02
Earnings History > 10 > surprise Percent
3.7736
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.44
Earnings History > 11 > eps Estimate
-0.51
Earnings History > 11 > eps Difference
0.07
Earnings History > 11 > surprise Percent
13.7255
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-16
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.49
Earnings History > 12 > eps Estimate
-0.43
Earnings History > 12 > eps Difference
-0.06
Earnings History > 12 > surprise Percent
-13.9535
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.41
Earnings History > 13 > eps Estimate
-0.44
Earnings History > 13 > eps Difference
0.03
Earnings History > 13 > surprise Percent
6.8182
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-10
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.38
Earnings History > 14 > eps Estimate
-0.41
Earnings History > 14 > eps Difference
0.03
Earnings History > 14 > surprise Percent
7.3171
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-12
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.36
Earnings History > 15 > eps Estimate
-0.4
Earnings History > 15 > eps Difference
0.04
Earnings History > 15 > surprise Percent
10
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-29
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.36
Earnings History > 16 > eps Estimate
-0.32
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-12.5
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.39
Earnings History > 17 > eps Estimate
-0.25
Earnings History > 17 > eps Difference
-0.14
Earnings History > 17 > surprise Percent
-56
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-09-08
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-3.17
Earnings History > 18 > eps Estimate
-0.19
Earnings History > 18 > eps Difference
-2.98
Earnings History > 18 > surprise Percent
-1568.4211
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-02
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.41
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.41
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-2.3874
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-2.3874
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.3434
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0.3434
Earnings History > 21 > surprise Percent
-
Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are NVL-520, a novel ROS1-selective inhibitor to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of ROS1 tyrosine kinase inhibitors (TKIs) for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC) which is under the Phase 2 portion of the ARROS-1 Phase 1/2 clinical trial; NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under the Phase 2 portion of the ALKOVE-1 clinical trial; and NVL-330, a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to treat tumors driven by HER2ex20, brain metastases, and avoiding treatment-limiting adverse events including due to off-target inhibition of wild-type EGFR that is in Phase 1a/1b clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AUBS reiterates Buy rating on Nuvalent stock, citing Royalty Pharma deal Investing.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$141.8235
Analyst Picks
Strong Buy
8
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 106.26% of the total shares of Nuvalent Inc
1.
Deerfield Management Co(24.9512%)
since
2025/06/30
2.
FMR Inc(13.8255%)
since
2025/06/30
3.
Paradigm Biocapital Advisors LP(7.308%)
since
2025/06/30
4.
Vanguard Group Inc(6.2744%)
since
2025/06/30
5.
BlackRock Inc(5.6116%)
since
2025/06/30
6.
Fidelity Growth Compy Commingled Pl S(3.3827%)
since
2025/07/31
7.
T. Rowe Price Associates, Inc.(2.4899%)
since
2025/06/30
8.
HHG PLC(2.4722%)
since
2025/06/30
9.
Fidelity Growth Company Fund(2.3788%)
since
2025/07/31
10.
Wellington Management Company LLP(2.1862%)
since
2025/06/30
11.
State Street Corp(2.0668%)
since
2025/06/30
12.
Vanguard Total Stock Mkt Idx Inv(2.0313%)
since
2025/07/31
13.
Bain Capital Life Sciences Investors, LLC(2.0072%)
since
2025/06/30
14.
Perceptive Advisors LLC(1.9072%)
since
2025/06/30
15.
COMMODORE CAPITAL LP(1.9069%)
since
2025/06/30
16.
JPMorgan Chase & Co(1.6603%)
since
2025/06/30
17.
BRAIDWELL LP(1.6308%)
since
2025/06/30
18.
Vanguard Small Cap Index(1.5646%)
since
2025/07/31
19.
T. Rowe Price Investment Management,Inc.(1.518%)
since
2025/06/30
20.
Vestal Point Capital LP(1.4909%)
since
2025/06/30
21.
iShares Russell 2000 ETF(1.4363%)
since
2025/08/31
22.
Geode Capital Management, LLC(1.3825%)
since
2025/06/30
23.
Woodline Partners LP(1.2541%)
since
2025/06/30
24.
Polar Capital Holdings PLC(1.1318%)
since
2025/06/30
25.
Fairmount Funds Management LLC(1.009%)
since
2025/06/30
26.
Vanguard Small Cap Value Index Inv(1.0085%)
since
2025/07/31
27.
Fidelity Select Health Care(0.9733%)
since
2025/07/31
28.
JPMorgan Mid Cap Growth I(0.9013%)
since
2025/07/31
29.
Polar Capital Biotech S Inc(0.8668%)
since
2025/07/31
30.
SPDR® S&P Biotech ETF(0.8191%)
since
2025/08/31
31.
Vanguard Health Care Inv(0.7412%)
since
2025/06/30
32.
Fidelity Growth Company K6(0.7287%)
since
2025/07/31
33.
US Small-Cap Growth II Equity Comp(0.7168%)
since
2025/06/30
34.
Fidelity Small Cap Growth(0.7111%)
since
2025/06/30
35.
T. Rowe Price New Horizons(0.6907%)
since
2025/07/31
36.
T. Rowe Price US Small-Cap Core Equity(0.6802%)
since
2025/06/30
37.
Fidelity Series Growth Company(0.6623%)
since
2025/07/31
38.
T. Rowe Price Small-Cap Stock(0.6514%)
since
2025/07/31
39.
JPM US Mid Cap Growth-Composite(0.6283%)
since
2025/06/30
40.
Fidelity Small Cap Index(0.5978%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-1.38
Date
2025-09-30
EPS Actual
-1.7
EPS Estimate
-1.36
EPS Difference
-0.34
Surprise Percent
-25%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.